Related Experiment Videos
Hypertrophic cardiomyopathy in Friedreich's ataxia: symmetric or asymmetric?
Insights
Friedreich
Area of Science:
- Cardiology
- Neurology
- Genetics
Background:
- Friedreich's ataxia (FA) is a rare inherited neurodegenerative disorder.
- Cardiac involvement, specifically hypertrophic cardiomyopathy, is a known complication of FA.
Purpose of the Study:
- To determine the incidence and type of myocardial involvement in patients with Friedreich's ataxia.
- To characterize the predominant form of cardiomyopathy in FA patients.
Main Methods:
- Evaluation of 15 patients diagnosed with Friedreich's ataxia.
- Utilized electrocardiography (ECG), vectocardiography, and echocardiography to assess cardiac abnormalities.
Main Results:
- All 15 FA patients exhibited cardiac abnormalities on ECG, vectocardiography, or echocardiography.
- Symmetric, concentric hypertrophic cardiomyopathy (SCH) was the predominant finding in 67% of patients.
- Contrary to previous reports, asymmetric septal hypertrophy (ASH) was less common.
Conclusions:
- Myocardial involvement is a consistent feature in Friedreich's ataxia patients.
- Symmetric, concentric hypertrophic cardiomyopathy is the primary cardiac manifestation in FA.
- Regular echocardiographic screening is crucial for early detection of cardiac hypertrophy in FA patients.
Abstract:
We evaluated 15 patients with Friedreich's ataxia (FA) to define the incidence of myocardial involvement and the type of cardiomyopathy observed. All patients with FA had either ECG, vectocardiographic or echocardiographic abnormalities, suggesting some degree of myocardial involvement. In contrast to reports indicating that asymmetric septal hypertrophy (ASH), often obstructive, is associated with FA, symmetric, concentric hypertrophic cardiomyopathy (SCH) was the predominant abnormality (sixty-seven percent of patients). Echocardiograms should be performed periodically in all FA patients since this technique allows the detection of cardiac hypertrophy.